Timing, fractionation, and dose of thoracic radiotherapy in patients with extensive-stage small cell lung cancer undergoing first-line Chemo-Immunotherapy

Puntos clave

• Radiotherapy timing significantly influences treatment outcomes in extensive-stage small cell lung cancer, enhancing survival rates.
• The study evaluates various dose fractionation schemes, with notable effects observed at specific intervals, indicating optimal scheduling.
• Assessment using treatment models highlights the importance of timely radiotherapy combined with chemo-immunotherapy in clinical practice.
• Findings may enable personalized treatment plans, emphasizing tailored therapy approaches based on radiotherapy timing.